Organization · Other
Corundum Systems Biology
Corundum Systems Biology Inc. is a Tokyo-based organization that invests in early-stage ventures focused on systems biology and multi-omics data to advance health solutions. They also have an office in Cambridge, Massachusetts.
Overview
What Corundum Systems Biology does
What Corundum Systems Biology is
Corundum Systems Biology Inc. is a Tokyo-based organization that invests in early-stage ventures focused on systems biology and multi-omics data to advance health solutions. They also have an office in Cambridge, Massachusetts.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Other
- Founded
- Founded in 2020
- Approximate age
- About 6 years
- Structured capabilities
- Funder
- Last reviewed
- March 19, 2026
Official channels
Find Corundum Systems Biology elsewhere
Open the official website or a supported primary organization account.
Capability profile
Corundum Systems Biology as a funder
Investment thesis
Corundum Systems Biology focuses on advancing the science of complexity in health through systems biology, supporting transformative breakthroughs by investing in early-stage ventures and foundational platforms.
Focus narrative
Corundum Systems Biology invests in scientific ventures that leverage multi-omics data and systems biology to create scalable health solutions. Their focus includes the microbiome field and the development of a multi-omics human database. They seek to partner with academic labs, biotech founders, and pharmaceutical leaders to foster long-term collaborations and translational impact.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series B · Series C · Growth Equity
- Regions
- Asia · Global · North America
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 8
Portfolio context
Notable portfolio companies include: Axial Therapeutics: Focuses on developing therapies for neurological disorders. Holobiome: Works on microbiome-based health solutions. Freya Biosciences: Engages in biotechnology innovations. Concerto Bio: Develops precision medicine approaches. Sequential Skin: Specializes in skin health diagnostics. Pheno.ai: Utilizes AI for health data analysis. ImYoo: A patient-powered health data platform. NimbleSci: Focuses on advanced scientific research.
Common questions
What to know about Corundum Systems Biology
Upseed classifies Corundum Systems Biology under the Other organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 19, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.